Strengthening Egyptian Drug Authority’s regulatory functions – EG 23 NDICI HE 01 25

The "Strengthening Egyptian Drug Authority’s regulatory functions" project, designated as EG 23 NDICI HE 01 25, offers a grant opportunity under the EU’s Neighbourhood, Development and International Cooperation Instrument (NDICI). The total budget for this initiative is set at 1,500,000 EUR. This call specifically targets strengthening the regulatory framework of the Egyptian Drug Authority (EDA) to achieve the status of a WHO-listed Authority, thereby enhancing the regulation of medicinal products, vaccines, and medical devices in Egypt.

The opportunity is open for submissions, with a deadline of September 2, 2025. Eligible applicants must be public administrations from EU Member States, forming a consortium to collaborate with the EDA, which acts as the beneficiary institution within Egypt. The project falls into the health sector, notably focusing on pharmaceuticals and healthcare regulation.

The application process reflects a two-stage submission: an initial concept note followed by a full proposal. Funding is classified as a grant, covering 100% of project costs without a co-funding requirement from Egypt. The project's emphasis is on capacity-building, technical assistance, and aligning Egyptian regulatory practices with EU standards.

Key documents related to this grant include the Twinning Fiche, which outlines the eligibility criteria and application details. The initiative ultimately aims to bolster the EDA's capabilities, contributing to public health improvements in Egypt while reinforcing EU-Egypt regulatory cooperation.

Strengthening Egyptian Drug Authority’s regulatory functions – EG 23 NDICI HE 01 25

This is an open call for submission of a grant.

General Information:

Programme: Neighbourhood.

Geographical Zone: Egypt.

Budget: 1,500,000 EUR.

Type: Action Grants.

Published: 01/07/2025.

Updated: 22/06/2025.

Deadline: 02/09/2025.

Documents:

Annex C9 Publication of Twinning Fiche, published 01 July 2025, in English.

Annex C1 Twinning Fiche, published 01 July 2025, in English.

The EU Funding & Tenders Portal manages this site via the Directorate-General for Research and Innovation.

Summary:

This is a call for action grant proposals focused on strengthening the regulatory functions of the Egyptian Drug Authority. The grant, with a budget of 1,500,000 EUR, falls under the Neighbourhood Programme and specifically targets Egypt. The call was published on July 1, 2025, and updated on June 22, 2025, with a submission deadline of September 2, 2025. Relevant documents, including the Twinning Fiche (Annex C1 and Annex C9), are available in English. Potential applicants should review these documents for detailed information on the objectives, eligibility criteria, and application process. The overall aim is to improve the Egyptian Drug Authority's capabilities through a twinning project.

Eligible Applicant Types: The provided text does not explicitly list eligible applicant types. However, the mention of "Twinning Fiche" suggests that the opportunity may be geared towards government agencies or organizations that can partner with the Egyptian Drug Authority to strengthen its regulatory functions. Further review of the Twinning Fiche document would be needed to confirm eligible applicant types.

Funding Type: Action Grants.

Consortium Requirement: The mention of "Twinning Fiche" strongly suggests a consortium or partnership approach, likely involving an EU member state entity partnering with the Egyptian Drug Authority. Therefore, it is likely a consortium is required.

Beneficiary Scope (Geographic Eligibility): The primary beneficiary is the Egyptian Drug Authority. The reference to "Twinning Fiche" implies that the partner should be from an EU Member State. Therefore, the geographic eligibility includes Egypt and EU Member States.

Target Sector: This program targets the pharmaceutical and healthcare sector, specifically focusing on strengthening the regulatory functions of the Egyptian Drug Authority.

Mentioned Countries: Egypt, EU Member States (implied through Twinning Fiche).

Project Stage: The project stage is likely focused on development and implementation of regulatory improvements, which suggests a stage beyond basic research and more towards practical application and strengthening existing systems.

Funding Amount: 1,500,000 EUR.

Application Type: Open Call, as indicated by "Open For Submission".

Nature of Support: Money, as it is an Action Grant.

Application Stages: The provided text does not explicitly state the number of application stages. However, the presence of documents like the "Twinning Fiche" suggests that there may be multiple stages, potentially including an initial expression of interest or concept note, followed by a full proposal. Further review of the call documents is needed to determine the exact number of stages.

Success Rates: The provided text does not include information on success rates.

Co-funding Requirement: The provided text does not explicitly mention a co-funding requirement. Review of the call documents would be needed to determine if co-funding is required.

Summary:

This opportunity is an Action Grant funded by the European Union under the Neighbourhood, Development and International Cooperation Instrument (NDICI). It aims to strengthen the regulatory functions of the Egyptian Drug Authority (EDA). The total budget for this action is 1,500,000 EUR. The call is open for submission, with a deadline of September 2, 2025. The program likely involves a "twinning" approach, where an organization or agency from an EU Member State partners with the EDA to provide expertise and support in enhancing its regulatory capabilities. Eligible applicants are likely to be government agencies or organizations capable of forming a twinning partnership. The project is focused on the development and implementation of regulatory improvements within the Egyptian pharmaceutical sector. The application process likely involves multiple stages. The specific details regarding application stages, success rates, and co-funding requirements would need to be confirmed by reviewing the official call documents, including the Twinning Fiche.